Literature DB >> 29125273

Expression and clinical significance of EGF and TGF-α in chronic pancreatitis and pancreatic cancer.

Chengfei Hao1, Zhonglian Li2, Xibo Zhang1, Hongtao Zhang1, Haitao Shang1, Jianheng Bao1, Haibo Wang1.   

Abstract

BACKGROUND: The purpose of this project was to investigate the expression and clinical significance of epidermal growth factor (EGF) and the transforming growth factor-α (TGF-α) in the occurrence and development of chronic pancreatitis and pancreatic cancer.
METHODS: We recruited 31 patients with chronic pancreatitis, 42 with pancreatic cancer, and 20 with normal pancreas in our hospital. Chronic pancreatitis, pancreatic cancer, and normal pancreas expressed EGF and TGF-α mRNAs as well as EGF and TGF-α proteins.
RESULTS: Immunofluorescence showed that EGF and TGF-α were expressed in chronic pancreatitis and pancreatic cancer, but the expression levels for both proteins were higher in pancreatic cancer. Variance analysis indicated that the differences in the expression levels of EGF and TGF-α in chronic pancreatitis, pancreatic cancer, and normal pancreas were statistically significant. The abnormally elevated expression of EGF and TGF-α are closely associated with the occurrence and development of chronic pancreatitis and pancreatic cancer.
CONCLUSIONS: EGF and TGF-α have important research value as indicators to assess the progression of these conditions and provide a new basis for the clinical diagnosis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29125273     DOI: 10.23736/S0391-1977.17.02721-3

Source DB:  PubMed          Journal:  Minerva Endocrinol        ISSN: 0391-1977            Impact factor:   2.184


  5 in total

1.  Major histocompatibility complex class I molecule expression by pancreatic cancer cells is regulated by activation and inhibition of the epidermal growth factor receptor.

Authors:  Shelby M Knoche; Alaina C Larson; Gabrielle L Brumfield; Steven Cate; William H Hildebrand; Joyce C Solheim
Journal:  Immunol Res       Date:  2022-03-18       Impact factor: 4.505

2.  FOXC1 plays a crucial role in the growth of pancreatic cancer.

Authors:  Ramadevi Subramani; Fernando A Camacho; Carly Ivy Levin; Kristina Flores; Alexa Clift; Adriana Galvez; Mauricio Terres; Servando Rivera; Sai Navana Kolli; Joshua Dodderer; Megan Miranda; Alejandro Rodriguez; Diego A Pedroza; Animesh Chatterjee; Rajkumar Lakshmanaswamy
Journal:  Oncogenesis       Date:  2018-07-06       Impact factor: 7.485

Review 3.  Deciphering role of FGFR signalling pathway in pancreatic cancer.

Authors:  Xiaodiao Kang; Zeng Lin; Minhui Xu; Jun Pan; Zhi-Wei Wang
Journal:  Cell Prolif       Date:  2019-04-03       Impact factor: 6.831

4.  Systematic Construction and Validation of a Novel Macrophage Differentiation-Associated Prognostic Model for Clear Cell Renal Cell Carcinoma.

Authors:  Chen Liu; Xuhui Zhang; Caoyang Hu; Xuezhi Liang; Xiaoming Cao; Dongwen Wang
Journal:  Front Genet       Date:  2022-06-14       Impact factor: 4.772

5.  Rab GTPase Mediating Regulation of NALP3 in Colorectal Cancer.

Authors:  Gülçin Tezcan; Ekaterina E Garanina; Margarita N Zhuravleva; Shaimaa Hamza; Albert A Rizvanov; Svetlana F Khaiboullina
Journal:  Molecules       Date:  2020-10-20       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.